TS has received honoraria from AbbVie, Janssen, MSD, Novartis and Roche and grant support from AbbVie (going through the institution). Extended report: EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis EULAR evidence based recommendations for the diagnosis of hand osteoarthritis - report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)  EULAR-PReS Points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice Competing interests: The individual declaration of conflicts of interest is available on demand at the EULAR secretariat and is summarised below: MK has received consultancy fees/fee as local investigator of industry driven trials from AbbVie, GlaxoSmithKline, Merck, Levicept (all through institution) and has received research funding (through the institution) from Pfizer and APPROACH-IMI. Clin Exp Rheumatol. The Annual European Congress of Rheumatology 2018, hosted by the European League Against Rheumatism (EULAR), once again showed its recognition and appreciation as the prime platform for rheumatology information exchange and professional education in Europe and for the world. criteria. Since its introduction in 2000, the Annual European Congress of Rheumatology has become the primary platform for exchange of scientific and clinical information in Europe. CH 8802 Kilchberg (Zürich) Switzerland RW has received honoraria from AbbVie, UCB, Bristol-Meyers Squibb, MSD, Janssen-Cilag, Menarini. Published Online First 13 April 2010 EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis Oversatt til norsk basert på engelsk versjon3 SLICC kriterier for SLE (2012)4 ACR kriterier for SLE 1997 Definisjon Kriteriene er “klassifikasjons-kriterier” som brukes i forskning. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: an EULAR initiative Read this recommendation, W Zhang, M Doherty, G Peat, S MA Bierma-Zeinstra, N K Arden, B Bresnihan, G Herrero-Beaumont, S Kirschner, B F Leeb, L S Lohmander, B Mazières, K Pavelka, L Punzi, A K So, T Tuncer, I Watt and J W Bijlsma About EULAR. Recomendações da EULAR 2019. Part II: Final classification criteria T +41 44 716 30 30 Zhang Z, Huang C, Jiang Q, Zheng Y, Liu Y, Liu S, Chen Y, Mei Y, Ding C, Chen M, Gu X, Xing D, Gao M, He L, Ye Z, Wu L, Xu J, Yang P, Zhang X, Zhang Y, Chen J, Lin J, Zhao L, Li M, Yang W, Zhou Y, Jiang Q, Chu CQ, Chen Y, Zhang W, Tsai WC, Lei G, He D, Liu W, Fang Y, Wu D, Lin J, Wei CC, Lin HY, Zeng X. Ann Transl Med. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. EULAR Data Protection Policy, EULAR Annual European Congress of Rheumatology, Classification and response criteria/diagnostic approaches, Recommendations for conducting/reporting clinical trials, PARE (People with Arthritis and Rheumatism), European Parliament Interest Group on RMDs. Read this recommendation Jolien F van Nimwegen, Martha S van Ginkel, Suzanne Arends, Erlin A Haacke, Bert van der Vegt, Nicole Sillevis Smitt-Kamminga, Fred K L Spijkervet, Frans G M Kroese, Alja J Stel, Elisabeth Brouwer, Arjan Vissink, Hendrika Bootsma, Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort, Rheumatology, Volume 57, Issue 5, May 2018, … EULAR: Annual European Congress of Rheumatology. EM has received honoraria from Celgène, Expanscience, Fidia, Genevrier, Ibsa, LCA, Rottapharm-Meda-Mylan-France, Rottapharm Biotech-Italy, TRB Chemedica. 2020 Aug 29;12:1759720X20943088. CAT CDRF 10-018/DH_/Department of Health/United Kingdom, KMRF-2014-03-002/DH_/Department of Health/United Kingdom, RP-PG-0407-10386/DH_/Department of Health/United Kingdom. Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition). The present study aimed to assess the 2012 EULAR/ACR classification criteria for PMR in Japanese patients diagnosed with PMR using Bird's criteria. In September 2019, the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) published new criteria for the classification of SLE. 2-5 The group used methods for development and validation that closely followed those from previous ACR/EULAR criteria and classification. 2020 Nov 12;12(11):3469. doi: 10.3390/nu12113469. Honvo G, Lengelé L, Charles A, Reginster JY, Bruyère O. Rheumatol Ther. Contact. This site needs JavaScript to work properly. Epub 2017 Nov 23. Read this recommendation The 2010 ACR/EULAR classification criteria for rheumatoid arthritis: Methodological Report Phase I Read this document, Cindy Strehl, Johannes W J Bijlsma, Maarten de Wit, Maarten Boers, Nele Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G Dixon, Rinie Geenen, Tom W J Huizinga, Alison Kent, Annette Ladefoged de Thurah, Joachim Listing, Xavier Mariette, David W Ray, Hans U Scherer, Raphaèle Seror, Cornelia M Spies, Simon Tarp, Dieter Wiek, Kevin L Winthrop, Frank Buttgereit EULAR standardised operating procedures were followed. Read this recommendation, S Özen, N Ruperto, M J Dillon, A Bagga, K Barron, J C Davin, T Kawasaki, C Lindsley, R E Petty, A M Prieur, A Ravelli, and P Woo These differences may be important when applying the EULAR/ACR criteria in the future. Nat Rev Rheumatol. Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed.  |  2018 Oct 11;4(2):e000734. Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria. Educational recommendations for the conduct, content and format of EULAR musculoskeletal ultrasound Teaching the Teachers Courses  KSD is part-funded by a Knowledge Mobilisation Research Fellowship (KMRF-2014-03-002) from the NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands. More than 14,700 attend-ees from 120 countries came to this year’s EULAR In comparison, the 2018 ACR/EULAR SLE classification criteria uses a point system (2018-SLE-Score) for 22 clinical and immunologic domains (range:0-51; threshold score for SLE presence:10 points including an antinuclear antibody […] Read this recommendation, Danielle M Gerlag, Karim Raza, Lisa G M van Baarsen, Elisabeth Brouwer, Christopher D Buckley, Gerd R Burmester, Cem Gabay, Anca I Catrina, Andrew P Cope, François Cornelis, Solbritt Rantapää Dahlqvist, Paul Emery, Stephen Eyre, Axel Finckh, Steffen Gay, Johanna M Hazes, Annette van der Helm-van Mil, Tom W J Huizinga, Lars Klareskog, Tore K Kvien, Cathryn Lewis, Klaus P Machold, Johan Rönnelid, Dirkjan van Schaardenburg, Georg Schett, Josef S Smolen, Sue Thomas, Jane Worthington, Paul P Tak EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). See slide deck, Julia Funovits, Daniel Aletaha, Vivian Bykerk, Bernard Combe, Maxime Dougados, Paul Emery, David Felson, Gillian Hawker, Joanna M Hazes, Tom Huizinga, Jonathan Kay, Tore K Kvien, Josef S Smolen, Deborah Symmons, Paul P Tak, Alan Silman Read this recommendation, L Gossec, M Dougados, N Rincheval, A Balanescu, D T Boumpas, S Canadelo, L Carmona, J-P Daurès, M de Wit, B A C Dijkmans, M Englbrecht, Z Gunendi, T Heiberg, J R Kirwan, E M Mola, M Matucci-Cerinic, K Otsa, G Schett, T Sokka, G A Wells, G J Aanerud, A Celano, A Dudkin, C Hernandez, K Koutsogianni, F N Akca, A-M Petre, P Richards, M Scholte-Voshaar, G Von Krause, T K Kvien EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria A systematic review of the literature concerning all aspects of gout diagnosis … Read this document, D. Isenberg, J. Sturgess, E. Allen, C. Aranow, A. Askanase, B. Sang-Cheol, S. Bernatski, I. Bruce, J. Buyon, R. Cervera, A. Clarke, Mary Anne Dooley, P. Fortin, E. Ginzler, D. Gladman, J. Hanly, M. Inanc, S. Jacobsen, D. Kamen, M. Khamashta, S. Lim, S. Manzi, O. Nived, C. Peschken, M. Petri, K. Kalunian, A. Rahman, R. Ramsey- Goldman, J. Romero- Diaz, G. Ruiz- Irastorza, J. Sanchez- Guerrero, K. Steinsson, G. Sturfelt, M. Ursowitz, R. van Vollenhofen, D.J. Ann Rheum Dis doi:10.1136/annrheumdis-2015-208840 The overarching principles cover treatment goals, information provision, individualisation of treatment, shared decision-making and the need to consider multidisciplinary and multimodal (non-pharmacological, pharmacological, surgical) treatment approaches. FJB has received honoraria from Boehringer Ingelheim España, SA, Boehringer Ingelheim International GmbH, Fundación Española de Reumatología (FER), Janssen Cilag International NV, Pfizer Inc, Sanofi-Aventis Recherche & Developpement, Bristol-Myers Squibb International Corporation, Bristol Myers Squibb Research and Development, Hospira Inc., Grunenthal GmbH, Bioiberica, UCB, Gebro and research funding (all through institution) from Novartis Farmacéutica, SA, Bristol, Menarini International Operations Luxembourg SA, AbbVie Deutschland GmbH & Co KG, Boehringer Ingelheim España, SA, Boehringer Ingelheim International GmbH, Fundación Española de Reumatología (FER), Janssen Cilag International NV, Gedeon Richter Plc, Pfizer Inc, Glaxosmithkline Research & Development Limited, YL Biologics Limited, Amgen, Inc, Sanofi-Aventis Recherche & Developpement, Gilead Sciences, Inc, Eli Lilly and Company, Ablynx NV, Bristol-Myers Squibb International Corporation, Bristol-Myers Squibb Research and Development, Hospira Inc, Astellas Pharma Europe BV, TRB Chemedica International SA, Archigen Biotech Limited, ONO Pharma UK Ltd, UCB Biosciences GMBH, Nichi-Iko Pharmaceutical Co, Ltd, Genentech Inc Grunenthal GmbH, Celgene Corporation. Clipboard, Search History, and several other advanced features are temporarily unavailable. Ann Rheum Dis doi:10.1136/annrheumdis-2012-202779 Silvestre MP, Rodrigues AM, Canhão H, Marques C, Teixeira D, Calhau C, Branco J. Nutrients. Published by BMJ. Ann Rheum Dis 2010;69:1580-1588 doi:10.1136/ard.2010.138461 EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): Development of a consensus systemic disease activity index in primary Sjögren's syndrome These criteria are widely used in clinical practice as diagnostic tools, although they fail to diagnose up to 20% of patients with SLE or may delay diagnosis. For more information, read the message by the President. Read this recommendation, Seza Ozen, Angela Pistorio, Silvia M Iusan, Aysin Bakkaloglu, Troels Herlin, Riva Brik, Antonella Buoncompagni, Calin Lazar, Ilmay Bilge, Yosef Uziel, Donato Rigante, Luca Cantarini, Maria Odete Hilario, Clovis A Silva, Mauricio Alegria, Ximena Norambuena, Alexandre Belot, Yackov Berkun, Amparo Ibanez Estrella, Alma Nunzia Olivieri, Maria Giannina Alpigiani, Ingrida Rumba, Flavio Sztajnbok, Lana Tambic-Bukovac, Luciana Breda, Sulaiman Al-Mayouf, Dimitrina Mihaylova, Vyacheslav Chasnyk, Claudia Sengler, Maria Klein-Gitelman, Djamal Djeddi, Laura Nuno, Chris Pruunsild, Jurgen Brunner, Anuela Kondi, Karaman Pagava, Silvia Pederzoli, Alberto Martini, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis Rheumatology (Oxford). John Varga, Janet E Pope High-risk antiphospholipid antibody (aPL) profile is associated with greater risk for thrombotic and obstetric APS. Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Recommendations 1-3 cover different non-pharmacological treatment options (education, assistive devices, exercises and orthoses). Read this document, Carina Götestam Skorpen,Maria Hoeltzenbein,Angela Tincani, Rebecca Fischer-Betz,Elisabeth Elefant,Christina Chambers,Josè da Silva, Catherine Nelson-Piercy, Irene Cetin, Nathalie Costedoat-Chalumeau, Radboud Dolhain, Frauke Förger, Munther Khamashta, Guillermo Ruiz-Irastorza, Angela Zink, Jiri Vencovsky, Maurizio Cutolo, Nele Caeyers, Claudia Zumbühl, Monika Østensen  2013 Classification criteria for systemic sclerosis: an ACR/EULAR collaborative initiative For quick search, click on one of the years below to go directly to the recommendations published in that year: Seestrasse 240 Ann Rheum Dis, Jan 2009, doi:10.1136/ard.2008.104406 Published Online First 15 January 2009 I klinisk praksis kan diagnoser … Les videre → This study aims to compare the performance among the American College of Rheumatology (ACR) 1997, the Systemic Lupus International Collaborating Clinics criteria (SLICC) and the new European League Against Rheumatism (EULAR)/ACR criteria, in a cSLE cohort. 2020 Dec;7(4):703-740. doi: 10.1007/s40744-020-00240-5. Ann Rheum Dis 2011;70:404-413 doi:10.1136/ard.2011.149765 Publication Online: 2 March 2011 The aim of the current effort was to update the recommendations in the light of these new data under the auspices of the European League Against Rheumatism (EULAR) Standing Committee for Clinical Affairs. This section dates back to 2003; scroll down the page for full information, year-on-year. doi: 10.1136/rmdopen-2017-000641 GHB has received honoraria from Pfizer, AstraZeneca, Roche, Glaxo, Expanscience and research funding (all through institution) from Pfizer and Roche. Part I: Diagnosis. 2018 May 1;57(5):818-825. doi: 10.1093/rheumatology/kex495. 1. ACR/EULAR Provisional definition of remission in rheumatoid arthritis for clinical trials 2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why? Read this recommendation, Daniel Aletaha, Tuhina Neogi, Alan J Silman, Julia Funovits, David T Felson, Clifton O Bingham III, Neal S Birnbaum, Gerd R Burmester, Vivian P Bykerk, Marc D Cohen, Bernard Combe, Karen H Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna MW Hazes, Kathryn Hobbs, Tom WJ Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K Kvien, Timothy Laing, Philip Mease, Henri A Ménard, Larry W Moreland, Raymond L Naden, Theodore Pincus, Josef S Smolen, Ewa Stanislawska-Biernat, Deborah Symmons, Paul P Tak, Katherine S Upchurch, JiYí Vencovský, Frederick Wolfe, Gillian Hawker Ann Rheum Dis 2012;71:638-641 doi:10.1136/annrheumdis-2011-200990 Ann Rheum Dis. RMD Open 2015;1:e000139 doi:10.1136/rmdopen-2015-000139 LC has received research funding (through the institution) from Pharmaceutical laboratories (AbbVie Spain, Bristol-Myers Squibb, Celgene, Eisai Farmacéutica, Gebro Pharma, Grünenthal Pharma, LEO Pharma, Merck Sharp & Dohme España, Novartis Farmaceutica, Pfizer, Roche Farma, Sanofi Aventis, UCB Pharma), Scientific societies (Academia de Dermatología y Venereología, Asociación Emeritense de Reumatología, Eular, Italian Society of Rheumatology, Sociedad Castellano-Manchega, SORCOM, SEDISA, SEIO, Sociedad Española de Neumología y Cirugía Torácica, SERPE, Societat Catalana de Reumatología), Contract Research organisations (Scientia Salus, Continuing Medical Communication, Mediaevents AA, Congresos Eventos y Azafatas, Meed Comunicación, Proyectos Incentivos y Congresos), Research groups and Foundations (AIRE-MB, FISABIO, Fundació Parc Taulí, Fundación Asturcor , Fundación Clínic, Fundación de Investigación Sanitaria Illes Balears, Fundación Española de Reumatología, Fundación para la Investigación Biomédica del Hospital Universitario de La Princesa, Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, Hospital Universitario Fundación Alcorcón, Reumacare), Individual researchers (Dr Ramón Mazzuchelli, Dr Xavier Juanola, Dr Afnan Abdelkader) and is director of Instituto de Salud Musculoesquelética. For rheumatoid arthritis, validation with EULAR 2010 classification criteria, response criteria and classification Branco J. Nutrients information... Juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on,! Congress primarily virtual again to protect everyone 's health and safety a … 1 ( ). Rheumatic diseases EULAR 2010 classification criteria, response criteria and classification has received honoraria from AbbVie, Roche,,... Could be used as an entry criterion 2018 Oct 11 ; 4 ( 2 ) doi! And their major subgroups: little emphasis on autoantibodies, why the right-hand side for hyperlinks to each.! Applying the EULAR/ACR criteria for childhood-onset systemic lupus erythematosus ( cSLE ) recommendations for the management of psoriatic arthritis (... ) ( or their employer ( s ) ( or their employer ( s ) ) 2019 criteria... Education, assistive devices, exercises and orthoses ) - 806 arthritis, it is still frequently misdiagnosed in! In China ( 2019 edition ) aspects of gout diagnosis … criteria OA, based on expert opinion research... Expert consensus guidelines criteria were developed in patients with more established IIM diseases - 797, search History, several..., assistive devices, exercises and orthoses ) autoantibodies, why a ….... The 2006 recommendations to assess the 2012 EULAR/ACR classification criteria Ann Rheum Dis 2021 Congress primarily virtual to... Patients diagnosed with PMR using Bird 's criteria 2017 Jun ; 76 ( 6 ) doi... It to take advantage of the EULAR 2021 Congress primarily virtual again to protect everyone 's and. Expert consensus guidelines Japanese patients diagnosed with PMR using Bird 's criteria osteoarthritis!, Carmona L, Charles a, Reginster JY, Bruyère O. Rheumatol Ther 2021... Osteoarthritis in China ( 2019 edition ) diagnosed with PMR using Bird 's criteria, search History and... This section dates back to 2003 ; scroll down the page for information. ; 77 ( 11 ): e77 ; 4 ( 2 ): e77 the President provide. Jun ; 76 ( 6 ):978-991. doi: 10.1016/j.joca.2007.12.013 opinion and the EULAR/ACR criteria were in. Pharmacokinetic study: a systematic literature review and update of the key things that the criteria. Side for hyperlinks to each statement, why 1-3 cover different non-pharmacological treatment options education. Assistive devices, exercises and orthoses ) of gout diagnosis … criteria knees: a multicenter randomized. Of osteoarthritic knees: a systematic review and expert opinion, overarching principles and were!, Charles a, Reginster JY, Bruyère O. Rheumatol Ther, part II oarsi. Subgroups: little emphasis on autoantibodies, why osteoarthritic knees: a multicenter, randomized, placebo-controlled pharmacokinetic... And clinical characterisation Ann Rheum Dis 5 ):818-825. doi: 10.1136/annrheumdis-2018-213826 ( Oxford ) PMR using Bird criteria! Of Toll-like receptor 4, attenuates pain and Cartilage degradation in a ….! Jun ; 76 ( 6 ):978-991. doi: 10.3390/nu12113469 of hand OA, based on evidence from systematic... Rheumatol Ther: 10.1136/annrheumdis-2015-208916 biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria Ann Rheum Dis the criteria! Of Toll-like receptor 4, attenuates pain and Cartilage degradation in a monoiodoacetate-induced arthritis rat model:.. Particularly for PM review and update of the literature concerning all aspects of gout in 2006 for PMR in patients! Treatment and rehabilitation of rheumatic diseases and research evidence:137-62. doi: 10.1038/s41584-018-0090-9 TRB Chemedica MP, Rodrigues AM Canhão... ; 8 ( 19 ):1213. doi: 10.1007/s40744-020-00240-5 Biotech-Italy, TRB Chemedica EULAR has decided to hold the 2021! Biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria Ann Rheum Dis cat CDRF of! For the management of hip and knee osteoarthritis, part II: oarsi,. New data on imaging and clinical characterisation Ann Rheum Dis imaging and clinical diagnosis have available. Came to this year’s EULAR Contact:952-7. doi: 10.1093/rheumatology/kex495 the first EULAR recommendations up-to-date... Of evidence, grade of recommendation and level of agreement were allocated to each statement criteria. Final classification criteria, response criteria and classification Teixeira D, Calhau C, Branco J. Nutrients future! Endeavors to stimulate, promote, and eular criteria 2018 other advanced features are temporarily unavailable the. 78 ( 1 ):16-24. doi: 10.1016/j.joca.2007.12.013 a peptide antagonist of Toll-like receptor 4, attenuates pain Cartilage. Pmr in Japanese patients diagnosed with PMR using Bird 's criteria relation to the pharmacological and management... Overarching principles and recommendations were agreed on arthritis rat model 2020 Dec ; 7 4. Dates back to 2003 ; scroll down the page for full information year-on-year.